R-FU Injection 25 mg/ml contains Fluorouracil (5-FU), a widely used antineoplastic (anticancer) agent for the treatment of various malignancies. Fluorouracil belongs to the antimetabolite class of chemotherapy drugs, which inhibit DNA and RNA synthesis in rapidly dividing cancer cells, ultimately preventing tumor growth and proliferation.
R-FU Injection is administered intravenously under strict medical supervision, providing direct delivery of the drug into the bloodstream for rapid therapeutic action. This formulation is used in the management of solid tumors and in combination with other chemotherapeutic agents for enhanced efficacy.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
R-FU Injection 25 mg/ml is indicated for the treatment of:
Colorectal cancer: Both primary and metastatic forms.
Breast cancer: As part of combination chemotherapy regimens.
Gastric cancer: Advanced or unresectable cases.
Pancreatic cancer: In combination with other antineoplastic agents.
Other solid tumors: Such as head and neck cancers, depending on physician guidance.
It is primarily used under oncology protocols to manage aggressive or advanced cancers and is often part of multidrug chemotherapy regimens.
Administered intravenously by a healthcare professional experienced in chemotherapy administration.
Dosage is individualized based on the patient’s body surface area, type of cancer, treatment regimen, and overall health.
Can be given as a bolus injection or continuous infusion, depending on the therapeutic protocol.
Close monitoring of blood counts, liver and kidney function, and patient response is essential during treatment.
Proper hydration and supportive care may be required to minimize adverse effects.
Fluorouracil is a pyrimidine analog that interferes with DNA and RNA synthesis in rapidly dividing cells:
Incorporates into RNA: Disrupts RNA processing and protein synthesis.
Inhibits thymidylate synthase: Blocks DNA synthesis, preventing cell replication.
Preferentially targets rapidly dividing cancer cells, while normal cells with slower division rates are less affected.
This mechanism makes Fluorouracil effective in slowing tumor growth and enhancing patient outcomes when combined with other chemotherapeutic agents.
Use only under experienced oncology supervision.
Monitor for bone marrow suppression, gastrointestinal toxicity, and liver or kidney impairment.
Inform your physician of allergies, ongoing medications, or pregnancy status.
Avoid exposure to the drug outside medical settings due to cytotoxicity.
R-FU Injection 25 mg/ml may cause side effects including:
Gastrointestinal disturbances: nausea, vomiting, diarrhea, mucositis
Bone marrow suppression: anemia, leukopenia, thrombocytopenia
Dermatological reactions: hand-foot syndrome, rash
Rarely, cardiotoxicity or neurotoxicity
Most side effects require close monitoring and dose adjustment under medical supervision.
Store R-FU Injection 25 mg/ml in a cool, dry place, 2–8°C, protected from light. Keep out of reach of children and handle with caution as a cytotoxic drug.
R-FU Injection 25 mg/ml is a critical chemotherapeutic agent for the treatment of solid tumors, providing effective cancer cell inhibition when administered safely under expert supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet